1-溴-4-甲氧基-2,3-二甲氧基苯 在
镍 作用下,
以
四氢呋喃 为溶剂,
反应 3.0h,
以to afford 871 mg of the title compound as a grey crystalline solid的产率得到3-bromo-6-methoxy-benzene-1,2-diamine
A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof; wherein R1-R7 are as disclosed in the specification and pharmaceutical uses thereof.
公式(I)的化合物或其药物可接受的盐或前药酯;其中R1-R7如说明书所述,及其药物用途。
BENZIMIDAZOLE DERIVATIVES
申请人:Novartis AG
公开号:EP1709006A1
公开(公告)日:2006-10-11
BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
申请人:Merck Patent GmbH
公开号:EP3672952A1
公开(公告)日:2020-07-01
BENZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS